StockData
Camp4 Therapeutics Corp logo

Camp4 Therapeutics Corp (CAMP) stock

CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.10+0.10 (+2.50%)

Close on Nov 18, 2026Market cap $257.29MP/E –Yield 0.00%

Camp4 Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Camp4 Therapeutics's price to sales ratio was 51.7× on Nov 11, 2026, against 46.9× a year earlier. Over the last 2 years it ranged from 0.5× to 151.7×, with a median of 46.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202651.7×−23.9
2025Dec 31, 202575.6×+61.6
2024Oct 31, 202414.0×–

More Camp4 Therapeutics figures

See a number that looks wrong?